Delivery Order 36F79718D0403-15B50526F00000183

Federal Medical Center Carswell issued a $22,725.09 delivery order to Daiichi Sankyo, Inc. on June 1, 2026, for TURALIO 125mg (pexidartinib), 120-count oral capsules, with ultimate completion by June 30, 2026. The order was placed under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). Place of performance is Basking Ridge, New Jersey. Daiichi Sankyo supplies this specialized medication—indicated for treatment of tenosynovial giant cell tumor—to VA healthcare facilities within Veterans...

Federal Medical Center Carswell issued a $22,725.09 delivery order to Daiichi Sankyo, Inc. on April 1, 2026, for TURALIO 125mg (120-count bottles) under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). The order is placed against a single-award blanket purchase agreement established with the VA National Acquisition Center on May 22, 2025, and effective through May 21, 2026, with four optional one-year renewal periods. The BPA ceiling is $80,206.95 and covers TURALIO in 125mg and 200mg...

Daiichi Sankyo, Inc. was awarded a delivery order valued at $22.1K by Federal Medical Center Carswell for the supply of TURALIO 125mg capsules (120 count) under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB). The contract represents a firm fixed-price delivery order with an ultimate completion date of December 4, 2025, and no set-aside designation was utilized. The product will be delivered to Basking Ridge, New Jersey, and represents one of several delivery orders the vendor has...

This delivery order awards $22.73M to Daiichi Sankyo, Inc. for the supply of TURALIO (pexidartinib) 125mg capsules in 120-count bottles, with an ultimate completion date of January 31, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and funded by Federal Medical Center Carswell, a civilian facility within the Department of Veterans Affairs. Daiichi Sankyo will perform the...

Daiichi Sankyo, Inc. was awarded a $22,061.05 delivery order by the Federal Medical Center Carswell for TURALIO 125mg in a 120-count bottle configuration, with an ultimate completion date of October 31, 2025. This firm fixed-price contract was issued without a set-aside designation under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule (FSS-61-IB). The award represents a continuation of Daiichi Sankyo's specialized pharmaceutical supply relationship with the federal...

The Department of Veterans Affairs Federal Medical Center Carswell awarded a $22.7K delivery order to Daiichi Sankyo, Inc. for 120 units of TURALIO 125mg capsules, a specialized pharmaceutical treatment for tenosynovial giant cell tumor, a rare musculoskeletal condition affecting veteran populations. This firm fixed-price delivery order, issued February 1, 2026, with completion scheduled for February 28, 2026, carries no socioeconomic set-aside designation and represents a single order against...

Daiichi Sankyo, Inc. received a delivery order award from the Federal Medical Center Carswell valued at $22,061.05 for the supply of TURALIO 125mg capsules (120-count) with a completion date of December 31, 2025. The contract is structured as a firm fixed-price delivery order under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and was issued without a set-aside designation. The products will be delivered to Basking Ridge, New Jersey. Daiichi Sankyo specializes in pharmaceutical...

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Daiichi Sankyo, Inc., a for-profit pharmaceutical manufacturer, for the provision of the drug pexidartinib (marketed as TURALIO) in 125mg capsule form. The $73,651.68 delivery order was placed against Daiichi Sankyo's existing Blanket Purchase Agreement (BPA) with the VA National Acquisition Center under the GSA Pharmaceuticals and Drugs Schedule. This unrestricted...

This is a federal contract award to Daiichi Sankyo, Inc., a pharmaceutical manufacturer, for the supply of TURALIO 125mg capsules. The contract, valued at $208,538.07, is a delivery order contract with a firm fixed price and was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 20. The contract has an ultimate completion date of September 30, 2026. Daiichi Sankyo, Inc. is the prime contractor, and the contract is not a set-aside. The company...

Takeda Pharmaceuticals America Inc., a subsidiary of Japan-based Takeda Pharmaceutical Company Limited, was awarded a delivery order valued at $107,748.24 by the Federal Correctional Institution Fort Worth on August 1, 2025, with completion targeted for August 31, 2025. The award represents a firm fixed-price delivery order under the General Services Administration's Pharmaceuticals and Drugs Schedule (FSS-61-IB) and does not utilize a set-aside designation. The contract calls for delivery of...